These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 10540960)

  • 1. Influence of olanzapine on cognitive functions and catalepsy in rats after single and chronic administration.
    Nowakowska E; Chodera A; Kus K
    Pol J Pharmacol; 1999; 51(4):295-300. PubMed ID: 10540960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant use of carbamazepine and olanzapine and the effect on some behavioral functions in rats.
    Nowakowska E; Kus K; Polański A; Burda K; Nowakowska A; Sadowski C
    Pharmacol Rep; 2011; 63(2):372-80. PubMed ID: 21602592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clozapine inhibits catalepsy induced by olanzapine and loxapine, but prolongs catalepsy induced by SCH 23390 in rats.
    Kalkman HO; Neumann V; Tricklebank MD
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):361-4. PubMed ID: 9089667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral pharmacology of olanzapine: a novel antipsychotic drug.
    Moore NA; Leander JD; Benvenga MJ; Gleason SD; Shannon H
    J Clin Psychiatry; 1997; 58 Suppl 10():37-44. PubMed ID: 9265915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of chronic treatment with olanzapine, clozapine and scopolamine on performance of a learned 8-arm radial maze task in rats.
    Ortega-Alvaro A; Gibert-Rahola J; Micó JA
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Jan; 30(1):104-11. PubMed ID: 16226364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinpirole, 8-OH-DPAT and ketanserin modulate catalepsy induced by high doses of atypical antipsychotics.
    Ninan I; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):603-8. PubMed ID: 10669905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavioral pharmacology of olanzapine, a novel "atypical" antipsychotic agent.
    Moore NA; Tye NC; Axton MS; Risius FC
    J Pharmacol Exp Ther; 1992 Aug; 262(2):545-51. PubMed ID: 1354253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential inhibition of dizocilpine-induced hyperlocomotion by olanzapine.
    Ninan I; Kulkarni SK
    Eur J Pharmacol; 1999 Feb; 368(1):1-7. PubMed ID: 10096763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine: preclinical pharmacology and recent findings.
    Moore NA
    Br J Psychiatry Suppl; 1999; (37):41-4. PubMed ID: 10211141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-cataleptic effects of clozapine, but not olanzapine and quetiapine, on SCH 23390- or raclopride-induced catalepsy in rats.
    Ahlqvist J; Isacson R; Wahlestedt C; Salmi P
    Eur Neuropsychopharmacol; 2003 May; 13(3):177-82. PubMed ID: 12729943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of olanzapine, risperidone, and quetiapine on serotonin 1A, 2A and 2C receptors in rat forebrain regions.
    Tarazi FI; Zhang K; Baldessarini RJ
    Psychopharmacology (Berl); 2002 May; 161(3):263-70. PubMed ID: 12021829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of adulthood olanzapine treatment on cognitive performance and neurotrophic factor content in male and female rats neonatally treated with quinpirole.
    Thacker SK; Perna MK; Ward JJ; Schaefer TL; Williams MT; Kostrzewa RM; Brown RW
    Eur J Neurosci; 2006 Oct; 24(7):2075-83. PubMed ID: 17067304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of subchronic treatments with atypical antipsychotic drugs on dopamine D2 and serotonin 5-HT2A receptors in the rat brain.
    Kusumi I; Takahashi Y; Suzuki K; Kameda K; Koyama T
    J Neural Transm (Vienna); 2000; 107(3):295-302. PubMed ID: 10821438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats.
    Terry AV; Warner SE; Vandenhuerk L; Pillai A; Mahadik SP; Zhang G; Bartlett MG
    Neuroscience; 2008 Oct; 156(4):1005-16. PubMed ID: 18801413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haloperidol, but not olanzapine, impairs cognitive performance after traumatic brain injury in rats.
    Wilson MS; Gibson CJ; Hamm RJ
    Am J Phys Med Rehabil; 2003 Nov; 82(11):871-9. PubMed ID: 14566156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Olanzapine: preclinical pharmacology and recent findings].
    Moore N
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1998 Jun; 18(3):91-5. PubMed ID: 9800200
    [No Abstract]   [Full Text] [Related]  

  • 17. Behavioral characteristics of olanzapine: an atypical neuroleptic.
    Fu Y; Zhu ZT; Chen LJ; Yu LP; Jin GZ
    Acta Pharmacol Sin; 2000 Apr; 21(4):329-34. PubMed ID: 11324461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine.
    Weiner I; Schiller D; Gaisler-Salomon I; Green A; Joel D
    Behav Pharmacol; 2003 May; 14(3):215-22. PubMed ID: 12799523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine: another psychotropic?
    Davis MP; Dickerson ED
    Am J Hosp Palliat Care; 2001; 18(2):129-32. PubMed ID: 11407129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Olanzapine increases slow-wave sleep: evidence for blockade of central 5-HT(2C) receptors in vivo.
    Sharpley AL; Vassallo CM; Cowen PJ
    Biol Psychiatry; 2000 Mar; 47(5):468-70. PubMed ID: 10704958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.